ROSENTHAL BOB 4
4 · BRUKER CORP · Filed Aug 16, 2024
Insider Transaction Report
Form 4
BRUKER CORPBRKR
ROSENTHAL BOB
Director
Transactions
- Exercise/Conversion
Common Stock
2024-08-15$24.00/sh+10,000$240,000→ 35,647 total - Exercise/Conversion
Stock Option (Right to Purchase)
2024-08-15−10,000→ 0 totalExercise: $24.00Exp: 2026-01-05→ Common Stock (10,000 underlying) - Sale
Common Stock
2024-08-15$63.14/sh−4,684$295,748→ 30,963 total - Exercise/Conversion
Common Stock
2024-08-15$20.83/sh+2,500$52,075→ 25,647 total - Exercise/Conversion
Stock Option (Right to Purchase)
2024-08-15−2,500→ 0 totalExercise: $20.83Exp: 2025-11-12→ Common Stock (2,500 underlying)
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.81 to $63.28, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The Stock Option granted to the Reporting Person on November 12, 2015 (the "Original Grant Date") vests in equal installments on the first, second and third anniversaries of the Original Grant Date.
- [F3]The Stock Option granted to the Reporting Person on January 5, 2016 (the "Original Grant Date") vests in equal installments on the first, second and third anniversaries of the Original Grant Date.